Baxter Operating Cash Flow Per Share 2010-2025 | BAX

Current and historical operating cash flow per share for Baxter (BAX) from 2010 to 2025. Operating cash flow per share can be defined as a measure of financial performance calculated as operating cash flow, expressed on a per share basis Baxter operating cash flow per share for the three months ending June 30, 2025 was $0.05.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $12.250B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.741B 26.94
Boston Scientific (BSX) United States $155.895B 37.18
Stryker (SYK) United States $147.123B 29.95
EssilorLuxottica (ESLOY) France $145.891B 0.00
Medtronic (MDT) Ireland $116.772B 16.47
Lonza Group Ag (LZAGY) Switzerland $49.160B 0.00
Haleon (HLN) United Kingdom $44.031B 25.15
ResMed (RMD) United States $42.217B 30.19
GE HealthCare Technologies (GEHC) United States $33.398B 15.70
Agilent Technologies (A) United States $33.278B 21.69
Terumo (TRUMY) Japan $27.302B 32.35
Koninklijke Philips (PHG) Netherlands $26.423B 17.48
Insulet (PODD) United States $23.078B 77.32
Zimmer Biomet Holdings (ZBH) United States $20.685B 13.17
Smith & Nephew SNATS (SNN) United Kingdom $16.192B 0.00
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $7.714B 28.33
Lantheus Holdings (LNTH) United States $4.023B 10.88
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.400B 23.79
Perrigo (PRGO) Ireland $3.224B 8.05
Prestige Consumer Healthcare (PBH) United States $3.221B 14.29
ICU Medical (ICUI) United States $3.005B 20.46
Haemonetics (HAE) United States $2.601B 11.61
LeMaitre Vascular (LMAT) United States $2.183B 46.82
Acuren (TIC) United States $2.054B 0.00
Curaleaf Holdings (CURLF) Canada $1.918B 0.00
Green Thumb Industries (GTBIF) United States $1.804B 77.48
AtriCure (ATRC) United States $1.776B 0.00
QuidelOrtho (QDEL) United States $1.742B 10.97
Phibro Animal Health (PAHC) United States $1.279B 16.35
AdaptHealth (AHCO) United States $1.261B 17.92
Tilray Brands (TLRY) Canada $1.222B 0.00
Neogen (NEOG) United States $1.216B 19.31
BioLife Solutions (BLFS) United States $1.201B 2508.00
Valneva SE (VALN) France $0.952B 0.00
InMode (INMD) Israel $0.898B 8.31
Kestra Medical Technologies (KMTS) United States $0.876B 0.00
Verano Holdings (VRNOF) United States $0.622B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.609B 0.00
SNDL (SNDL) Canada $0.589B 0.00
Cresco Labs (CRLBF) United States $0.587B 0.00
ZimVie (ZIMV) United States $0.534B 20.58
Surmodics (SRDX) United States $0.516B 0.00
Evolus (EOLS) United States $0.480B 0.00
VAREX IMAGING (VREX) United States $0.471B 16.20
CeriBell (CBLL) United States $0.428B 0.00
Owens & Minor (OMI) United States $0.392B 3.48
Sanuwave Health (SNWV) United States $0.354B 0.00
Capricor Therapeutics (CAPR) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Omeros (OMER) United States $0.305B 0.00
TerrAscend (TSNDF) Canada $0.303B 0.00
Canopy Growth (CGC) Canada $0.297B 0.00
Brainsway (BWAY) Israel $0.283B 57.65
Viemed Healthcare (VMD) United States $0.273B 20.74
High Tide (HITI) Canada $0.273B 0.00
Sanara MedTech (SMTI) United States $0.272B 0.00
Aurora Cannabis (ACB) Canada $0.270B 0.00
Vireo Growth (VREOF) United States $0.231B 0.00
Cerus (CERS) United States $0.230B 0.00
Quanterix (QTRX) United States $0.225B 0.00
Exagen (XGN) United States $0.220B 0.00
Organigram Global (OGI) Canada $0.210B 0.00
OraSure Technologies (OSUR) United States $0.209B 0.00
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.184B 15.37
FitLife Brands (FTLF) United States $0.155B 19.10
Biote (BTMD) United States $0.149B 4.95
Jushi Holdings (JUSHF) United States $0.131B 0.00
Fonar (FONR) United States $0.094B 12.17
Quipt Home Medical (QIPT) United States $0.092B 0.00
MacroGenics (MGNX) United States $0.091B 0.00
Jin Medical (ZJYL) China $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.084B 0.00
Apyx Medical (APYX) United States $0.078B 0.00
Safety Shot (SHOT) United States $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.054B 31.47
Cytosorbents (CTSO) United States $0.053B 0.00
Veru (VERU) United States $0.052B 0.00
Zynex (ZYXI) United States $0.046B 0.00
Nephros (NEPH) United States $0.043B 33.50
Rockwell Medical (RMTI) United States $0.040B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 14.82
Trinity Biotech (TRIB) Ireland $0.028B 0.00
Senestech (SNES) United States $0.022B 0.00
INLIF (INLF) $0.017B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00